Alessio Fiorin

Alessio Fiorin

Auto-generated profile, based on publicly available information

Alessio Fiorin

Oncological Pathology and Bioinformatics Research Group, Institut de Recerca Biomèdica Catalunya Sud (IRB CatSud), Tortosa, Spain.

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 May 2024 in Journal of Imaging Informatics in Medicine
Verified
Journal Article
Open access
PDF file
AFAlessio Fiorin
Alessio Fiorin
CLCarlos López
Carlos López
Marylène LejeuneMarylène Lejeune
Marylène Lejeune
ASAmeer Hamza Siraj
Ameer Hamza Siraj
Vincenzo Della MeaVincenzo Della Mea
Vincenzo Della Mea
The field of immunology is fundamental to our understanding of the intricate dynamics of the tumor microenvironment. In particular, tumor-infiltrating lymphocyte (TIL) assessment emerges as essential aspect in breast cancer cases. To gain comprehensive insights, the quantification of TILs through computer-assisted pathology (CAP) tools has become a prominent approach, employing advanced artificial intelligence models based on deep learning techniques. The successful recognition of TILs requires the models to be trained, a process that demands access to annotated datasets. Unfortunately, this task is hampered not only by the scarcity of such datasets, but also by the time-consuming nature of the annotation phase required to create them. Our review endeavors to examine publicly accessible datasets pertaining to the TIL domain and thereby become a valuable resource for the TIL community. The overall aim of the present review is thus to make it easier to train and validate current and upcoming CAP tools for TIL assessment by inspecting and evaluating existing publicly available online datasets.

5 October 2024
Verified
Book Chapter
Closed access
PDF file
AFAlessio Fiorin
Alessio Fiorin
LLLaia Adalid Llansa
Laia Adalid Llansa
EGElena Goyda
Elena Goyda
Vincenzo Della MeaVincenzo Della Mea
Vincenzo Della Mea
AKANNA KORZYNSKA
ANNA KORZYNSKA
CLCarlos López
Carlos López

7 March 2026 in Biomedical Signal Processing and Control
Verified
Journal Article
Open access
SAShrief Abdelazeez
Shrief Abdelazeez
AFAlessio Fiorin
Alessio Fiorin
Vincenzo Della MeaVincenzo Della Mea
Vincenzo Della Mea
LALaia Adalid
Laia Adalid
KSKrzysztof Siemion
Krzysztof Siemion
AKAnna Korzynska
Anna Korzynska

3 July 2026 in Breast Cancer Research
Verified
Journal Article
Open access
AFAlessio Fiorin
Alessio Fiorin
LALaia Adalid-Llansa
Laia Adalid-Llansa
LRLaia Reverté
Laia Reverté
ESEsther Sauras-Colón
Esther Sauras-Colón
NGNoèlia Gallardo
Noèlia Gallardo
CLCarlos López
Carlos López
Tumor-infiltrating lymphocytes (TILs) are prognostic biomarkers in breast cancer (BC), particularly in HER2-positive and triple-negative subtypes. Assessment follows the international guidelines, in which pathologists evaluate whole hematoxylin and eosin (H&E)-stained slides while integrating representative regions of the invasive tumor. However, manual region selection can be labor-intensive, subjective, and may introduce variability, particularly across consecutive tissue sections. Automated region of interest (ROI) registration may mitigate this limitation, yet its impact on longitudinal TIL scoring has not been systematically evaluated. Here, we introduce three ROI registration strategies (direct, intermediate, and serial with/without quality control) and present an automated framework validated for consistent TIL scoring and clinical relevance in predicting relapse. We analyzed 104 invasive BC cases, each with 12 consecutive H&E slides. A pathologist annotated ROIs on both the first and twelfth slides. We registered these ROIs using the proposed strategies. We then evaluated them with performance metrics, including Intersection over Union (IoU), Dice Similarity Coefficient (DSC), failure rate, and execution time. Two pathologists scored TILs on manual and automated ROIs. We assessed longitudinal consistency between the first manual ROI and the twelfth slide's corresponding ROIs. We also tested whether the association between TIL score and patient relapse outcomes was preserved. The direct registration strategy achieved the highest geometric accuracy (mean IoU = 0.650, DSC = 0.769), with < 1% failure rate and ∼5.8 s execution time. TIL scores for both manual and automated ROIs closely matched (P = 0.84), showing strong agreement (Spearman's ρ = 0.923, ICC = 0.936, CCC = 0.915, Cohen's κ = 0.786). Longitudinal analyses showed no significant variability across distant sections (P = 0.79 and P = 0.62). TIL concentrations differed significantly between patients with and without relapse, and this association was preserved on both the first and twelfth slides (P < 0.05). We present the first automated framework for longitudinal ROI registration to support TIL scoring in BC. By reducing manual effort and variability, the framework supports scalable evaluation of immune biomarkers across tissue depth while preserving clinically relevant signals, supporting precision immuno-oncology applications.

29 May 2026 in IEEE Access
Verified
Journal Article
Open access
ASAntoine Schieb
Antoine Schieb
BHBilal Hadjadji
Bilal Hadjadji
NBNatalia Fernanda Valderrama Barrera
Natalia Fernanda Valderrama Barrera
DMDaniel Tshokola Mweze
Daniel Tshokola Mweze
VDValentin Derangère
Valentin Derangère
LMLouis-Oscar Morel
Louis-Oscar Morel
Histopathology slide digitization introduces scanner-induced domain shift that can significantly impact computational pathology models based on deep learning methods. In the state-of-the-art, this shift is often characterized at a broad scale (slide-level or dataset-level), but not at the patch level, which limits our comprehension of the impact of localized tissue characteristics on model accuracy. To address this challenge, we present a domain shift analysis framework based on UWarp, a novel registration tool designed to accurately align histological slides scanned under varying conditions. UWarp employs a hierarchical registration approach, combining global affine transformations with fine-grained local corrections to achieve robust tissue patch alignment. We evaluate UWarp using two private datasets, CypathLung and one from the BosomShield project, containing whole slide images scanned by multiple devices. Our experiments show that UWarp outperforms existing open-source registration methods, achieving a median target registration error (TRE) below 4 pixels (<1 μm at 40× magnification), compared to 21 pixels (~5 μm at 40×) for the best state-of-the-art algorithm, while significantly reducing computational time. Additionally, we perform a localized characterization of scanner-induced domain shift by analyzing the predictions of a deep learning model for breast cancer pathological response. Accurate patch-level alignment between scanners is ensured using UWarp. Our analysis reveals that prediction variability correlates with tissue versus background ratio and nuclei density at patch level, highlighting the importance of accounting for localized domain shift to improve model robustness and adaptation strategies in computational pathology.

30 July 2025 in Research Square
Verified
Preprint
Open access
PDF file
LQLaura Quintana Quintana
Laura Quintana Quintana
ESEsther Sauras-Colón
Esther Sauras-Colón
AFAlessio Fiorin
Alessio Fiorin
JSJavier Santana-Nunez
Javier Santana-Nunez
Samuel OrtegaSamuel Ortega
Samuel Ortega
CLCarlos López
Carlos López
Metastasis occurs in nearly 1 out of 3 breast cancer (BC) patients and significantly reduces survival rates, particularly in cases of distant metastases. As most distant metastases develop after diagnosis (i.e., recurrence) and remain incurable, there is a critical need for prognostic biomarkers to assess recurrence risk. Multimodal data analysis has emerged as a promising approach to integrate diverse information, offering a more comprehensive perspective. This study introduces the Histology HSI-BC (hyperspectral imaging - breast cancer) Recurrence Database, the first publicly accessible multimodal database designed to advance BC distant recurrence prediction. The database comprises 47 histopathological whole-slide images, 677 hyperspectral (HS) images, and clinical and demographic data from 47 BC patients, of whom 22 (47%) experienced distant recurrence over a 12-year follow-up. Histopathological slides were digitized using a whole-slide scanner and annotated by expert pathologists, while HS images were acquired with an HS camera coupled to a bright-field microscope. This database provides a promising resource for studying BC recurrence prediction and personalized treatment strategies by integrating the aforementioned multimodal data.